Many investors expect that these drugs might be approved, at least in some patients, based only on studies of their cholesterol-lowering potency, not hard proof they prevent heart attacks and strokes.

FORBES: Merck's Big Vytorin Study Could Change Rules For New Cholesterol Drugs

These schools encourage critical reflection, and some of their best students go on to social-science-based postgraduate studies in universities in the West.

CNN: The Ties That Do Not Bind